Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Chen, Si ^a   Wang, Qian ^a   Wu, Ziyan ^a   Li, Yuan ^a   Li, Ping ^a   Sun, Fei ^a   Zheng, Wenjie ^a   Wu, Qingjun ^a   Wu, Chanyuan ^a   Deng, Chuiwen ^a   Zhang, Fengchun ^a   Li, Yongzhe ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 5; DEAD BOX PROTEIN; DNA BINDING PROTEIN; IFIH1 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DERMATOMYOSITIS; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; INTERFERON INDUCED HELICASE 1 GENE; INTERFERON REGULATORY FACTOR 5 GENE; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; POLYMYOSITIS; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 GENE; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; COMPLICATION; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON REGULATORY FACTORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MODELS, GENETIC; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMYOSITIS;

EID: 84908266067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110044     Document Type: Article

References (52)

1. Dimachkie MM, Barohn RJ, Amato AA (2014) Idiopathic Inflammatory Myopathies. Neurol Clin 32: 595-628.
2. Ginn LR, Lin JP, Plotz PH, Bale SJ, Wilder RL, et al. (1998) Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 41: 400-405.
3. Niewold TB, Wu SC, Smith M, Morgan GA, Pachman LM (2011) Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 127: e1239-e1246.
4. Chinoy H, Lamb JA, Ollier WE, Cooper RG (2011) Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther 13: 216.
5. Hassan AB, Nikitina-Zake L, Sanjeevi CB, Lundberg IE, Padyukov L (2004) Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1∗03) with polymyositis and dermatomyositis. Arthritis Rheum 50: 1013-1015.
6. Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, et al. (2000) TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 43: 2368-2377.
7. Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James-Newton L, et al. (2008) Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum 58: 3941-3950.
8. Chinoy H, Salway F, John S, Fertig N, Tait BD, et al. (2007) Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46: 1411-1416.
9. Chinoy H, Salway F, John S, Fertig N, Tait BD, et al. (2007) Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK. Ann Rheum Dis 66: 970-973.
10. Gono T, Kawaguchi Y, Sugiura T, Furuya T, Kawamoto M, et al. (2010) Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Mod Rheumatol 20: 466-470.
11. Werth VP, Berlin JA, Callen JP, Mick R, Sullivan KE (2002) Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol 119: 1394-1399.
12. Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, et al. (2008) The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum 58: 3247-3254.
13. Sugiura T, Kawaguchi Y, Goto K, Hayashi Y, Tsuburaya R, et al. (2012) Positive association between STAT4 polymorphisms and polymyositis/dermatomyositis in a Japanese population. Ann Rheum Dis 71: 1646-1650.
14. Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, et al. (2013) Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 65: 3239-3247.
15. Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40: 1062-1064.
16. Musone SL, Taylor KE, Nititham J, Chu C, Poon A, et al. (2011) Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes Immun 12: 176-182.
17. Koumakis E, Giraud M, Dieude P, Cohignac V, Cuomo G, et al. (2012) Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum 64: 2746-2752.
18. Chinoy H, Li CK, Platt H, Fertig N, Varsani H, et al. (2012) Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 51: 794-799.
19. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, et al. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38: 617-619.
20. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
21. Sutherland A, Davies J, Owen CJ, Vaikkakara S, Walker C, et al. (2007) Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab 92: 3338-3341.
22. Cen H, Wang W, Leng RX, Wang TY, Pan HF, et al. (2013) Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 46: 455-462.
23. Barnes BJ, Moore PA, Pitha PM (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276: 23382-23390.
24. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, et al. (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74: 1125-1138.
25. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104: 6758-6763.
26. Sharif R, Mayes MD, Tan FK, Gorlova OY, Hummers LK, et al. (2012) IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis 71: 1197-1202.
27. Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, et al. (2007) An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16: 3008-3016.
28. Zhou X, Dimachkie MM, Xiong M, Tan FK, Arnett FC (2004) cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies. Med Sci Monit 10: R191-R197.
29. De Paepe B, Creus KK, De Bleecker JL (2007) Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. Ann N Y Acad Sci 1109: 441-453.
30. Lopez DPC, Vallejo AN, McNallan KT, Vehe R, Smith SA, et al. (2007) Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 56: 1658-1668.
31. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347.
32. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403-407.
33. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
34. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
35. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
36. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et al. (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
37. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-159.
38. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46: 626-636.
39. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
40. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
41. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
42. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: 1052-1060.
43. Vereecke L, Beyaert R, van Loo G (2009) The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30: 383-391.
44. Lee EG, Boone DL, Chai S, Libby SL, Chien M, et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354.
45. Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, et al. (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43: 908-912.
46. Chu Y, Vahl JC, Kumar D, Heger K, Bertossi A, et al. (2011) B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117: 2227-2236.
47. Mimori T (1987) Scleroderma-polymyositis overlap syndrome. Clinical and serologic aspects. Int J Dermatol 26: 419-425.
48. Dayal NA, Isenberg DA (2002) SLE/myositis overlap: are the manifestations of SLE different in overlap disease? Lupus 11: 293-298.
49. Takeuchi O, Akira S (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
50. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
51. Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, et al. (2007) Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 56: 3784-3792.
52. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76: 528-537.